Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using PDE 5 inhibitors

• 1. 使用PDE4抑制剂用于治疗和控制自身免疫性疾病和炎性疾病的方法和组合物 [P] . 中国专利： CN103635188B . 2017.03.22
• 2. 使用PDE4抑制剂用于治疗和控制自身免疫性疾病和炎性疾病的方法和组合物 [P] . 中国专利： CN103635188A . 2014-03-12
• 3. METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT SYMPTOMS BY USING PDE 5 INHIBITORS [P] . 美国专利： US2009105282A1 . 2009-04-23

  机译： 使用PDE 5抑制剂治疗良性前列腺增生或下尿路症状的方法

• 4. METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACK SYMPTOMS BY USING PDE 5 INHIBITORS [P] . 世界知识产权组织专利： WO2006104870A3 . 2006-12-28

  机译： 使用PDE 5抑制剂治疗良性前列腺增生或下尿路症状的方法

• 5. METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACK SYMPTOMS BY USING PDE 5 INHIBITORS [P] . 世界知识产权组织专利： WO2006104870A2 . 2006-10-05

  机译： 使用PDE 5抑制剂治疗良性前列腺增生或下尿路症状的方法

• 1. The effect of α-blocker therapy on erectile functions in patients with lower urinary tract symptoms due to benign prostate hyperplasia [J] . Omer Demir, Ismail Ozdemir, Ozan Bozkurt, 亚洲男性学杂志：英文版 . 2009,第006期
• 2. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015
• 3. The association of caffeine intake with components of lower urinary tract symptoms (LUTS) among cancer survivors. [D] . Anan, Hadeel F. 2016
• 4. Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-IsRelative to Monotherapies in Treating Lower Urinary Tract Symptoms and ErectileDysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis [O] . Yumeng Chai, Yong Zhang 2021
• 5. PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction [O] . Burge R., Le T.K., Viktrup L., 2011

• 1. An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction, and lower urinary tract symptoms secondary to benign prostatic hyperplasia [J] . Zhe Jin ,Zhi-Chao Zhang ,Ji-Hong Liu . 亚洲男性学杂志：英文版 . 2011,第4期
• 2. Association of Increased Urine Brain Derived Neurotrophic Factor with Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia [J] . Long-wang WANG ,Jian-long LI ,Yi YU . 华中科技大学学报（医学）（英德文版） . 2017,第004期
• 3. Effect of self-management on lower urinary tract symptoms and life quality of benign prostatic hyperplasia patients [J] . 陈晔 . 外科研究与新技术 . 2011,第4期
• 4. Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia? [J] . Li Tao Zhang ,Jong Kwan Park . 世界肾病学杂志：英文版 . 2015,第1期
• 5. 中药联合坦索洛新治疗良性前列腺增生下尿路症状疗效观察 [C] . 孙志兴 . 世界中联第五届男科国际学术大会、中华中医药学会第十二次全国中医男科学术大会、国际中医男科第七届学术大会、第二届海峡两岸中医男科学术论坛 . 2012
• 6. 雷火灸联合多沙唑嗪治疗脾肾亏虚型前列腺增生下尿路症状的临床观察 [A] . 廖萍 . 2019